Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ELICERA-THERAPEUTICS-AB-123687601/news/Elicera-Enters-Agreement-with-Prominent-US-Cancer-Center-to-Evaluate-the-Use-of-ITANK-in-T-Cell-Rece-46101808/?utm_source=whatsapp&utm_medium=social&utm_campaign=share